ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Internal Medicine

Top Internal Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
OM SHARMA M.D.

Internal Medicine

25,647

$1.46M

878
795 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

CAROL MILLER-SCHAEFFER MD

Internal Medicine

25,390

$1.38M

682
565 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

KAMLA MISHRA MD

Internal Medicine

25,054

$1.03M

636
504 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $58

LAURA MANTINE M.D.

Internal Medicine

24,906

$3,064

283
244 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$0
Average prescription price

Avg: $58

OSCAR MURILLO MD, FACP, AGSF

Internal Medicine

24,111

$1.34M

683
653 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

MAYA TSYSINA M.D.

Internal Medicine

24,071

$1.34M

424
369 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

JUDE SIDARI MD

Internal Medicine

23,907

$1.36M

653
525 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

DILIP ELANGBAM MD

Internal Medicine

23,788

$1.11M

729
644 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $58

AHMAD WARDEH MD

Internal Medicine

23,636

$1.44M

511
387 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

JAMES BRUNO M.D.

Internal Medicine

23,603

$1.15M

639
555 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

SWAMIKKAN NALLATHAMBI MD

Internal Medicine

23,409

$1.46M

1021
751 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $58

KENNETH HOELLEIN MD

Internal Medicine

23,382

$1.58M

658
394 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $58

LEOCADIA PRAWDZIK MD

Internal Medicine

23,289

$1.37M

586
454 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

DHINESH SAMUEL MD

Internal Medicine

23,218

$1.35M

731
637 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

ANTHONY VEGLIA MD

Internal Medicine

22,912

$1.23M

684
612 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

VINOD KATARIA M.D.

Internal Medicine

22,898

$1.02M

476
416 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

RICHARD KATZ M.D.

Internal Medicine

22,855

$994K

449
396 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

2%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $58

WILLIAM LORETAN D.O.

Internal Medicine

22,797

$1.15M

835
774 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

ARUN MOHANTY MD

Internal Medicine

22,694

$1.07M

563
327 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $58

DONALD COREY MD

Internal Medicine

22,612

$1.15M

813
742 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $58

IRENEUSZ SZULAWSKI M.D.

Internal Medicine

22,475

$957K

848
740 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $58

CHONG KIM M.D.

Internal Medicine

22,412

$1.27M

916
808 are 65+

1%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

PHILIP BENYO MD

Internal Medicine

22,407

$978K

686
591 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

GUBBI RANGANATH MD

Internal Medicine

22,396

$949K

535
436 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $58

NICHOLAS DODGE MD

Internal Medicine

22,081

$1.3M

417
332 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank